BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22226006)

  • 1. Observational epidemiology within randomized clinical trials: getting a lot for (almost) nothing.
    Howard G; Howard VJ
    Prog Cardiovasc Dis; 2012; 54(4):367-71. PubMed ID: 22226006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles.
    Shrier I; Boivin JF; Steele RJ; Platt RW; Furlan A; Kakuma R; Brophy J; Rossignol M
    Am J Epidemiol; 2007 Nov; 166(10):1203-9. PubMed ID: 17712019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observational studies are complementary to randomized controlled trials.
    Grootendorst DC; Jager KJ; Zoccali C; Dekker FW
    Nephron Clin Pract; 2010; 114(3):c173-7. PubMed ID: 19955822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet and cancer: the disconnect between epidemiology and randomized clinical trials.
    Meyskens FL; Szabo E
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1366-9. PubMed ID: 15941942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nested randomized trials in large cohorts and biobanks: studying the health effects of lifestyle factors.
    Ioannidis JP; Adami HO
    Epidemiology; 2008 Jan; 19(1):75-82. PubMed ID: 18090999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods in epidemiology: observational study designs.
    DiPietro NA
    Pharmacotherapy; 2010 Oct; 30(10):973-84. PubMed ID: 20874034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal studies and determination of risk.
    Murphy SW
    Methods Mol Biol; 2009; 473():19-37. PubMed ID: 19160730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primer: challenges in randomized and observational studies.
    Landewé R; van der Heijde D
    Nat Clin Pract Rheumatol; 2007 Nov; 3(11):661-6. PubMed ID: 17968337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond randomized controlled trials: a critical comparison of trials with nonrandomized studies.
    Sørensen HT; Lash TL; Rothman KJ
    Hepatology; 2006 Nov; 44(5):1075-82. PubMed ID: 17058242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using routine data to complement and enhance the results of randomised controlled trials.
    Lewsey JD; Leyland AH; Murray GD; Boddy FA
    Health Technol Assess; 2000; 4(22):1-55. PubMed ID: 11074392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some observations on observational research.
    Bluhm R
    Perspect Biol Med; 2009; 52(2):252-63. PubMed ID: 19395823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From randomized controlled trials to observational studies.
    Silverman SL
    Am J Med; 2009 Feb; 122(2):114-20. PubMed ID: 19185083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing the issue of channeling bias in observational studies with propensity scores analysis.
    Lobo FS; Wagner S; Gross CR; Schommer JC
    Res Social Adm Pharm; 2006 Mar; 2(1):143-51. PubMed ID: 17138506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observational studies in the era of randomized trials: finding the balance.
    Castillo RC; Scharfstein DO; MacKenzie EJ
    J Bone Joint Surg Am; 2012 Jul; 94 Suppl 1():112-7. PubMed ID: 22810460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of study design on outcome after endovascular abdominal aortic aneurysm repair. A comparison between the randomized controlled DREAM-trial and the observational EUROSTAR-registry.
    Leurs LJ; Buth J; Harris PL; Blankensteijn JD
    Eur J Vasc Endovasc Surg; 2007 Feb; 33(2):172-6. PubMed ID: 17097901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The utility of observational studies in clinical decision making: lessons learned from statin trials.
    Foody JM; Mendys PM; Liu LZ; Simpson RJ
    Postgrad Med; 2010 May; 122(3):222-9. PubMed ID: 20463433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized and observational studies in nephrology: how strong is the evidence?
    Greene T
    Am J Kidney Dis; 2009 Mar; 53(3):377-88. PubMed ID: 19185399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations.
    Hammad TA; Pinheiro SP; Neyarapally GA
    Clin Trials; 2011 Oct; 8(5):559-70. PubMed ID: 21878445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based medicine, systematic reviews, and guidelines in interventional pain management: part 6. Systematic reviews and meta-analyses of observational studies.
    Manchikanti L; Datta S; Smith HS; Hirsch JA
    Pain Physician; 2009; 12(5):819-50. PubMed ID: 19787009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection criteria and generalizability within the counterfactual framework: explaining the paradox of antidepressant-induced suicidality?
    Weisberg HI; Hayden VC; Pontes VP
    Clin Trials; 2009 Apr; 6(2):109-18. PubMed ID: 19342462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.